News and Press Releases
Cytomos appoints new Chief Commercial and Innovation Officer and Techno-Commercial Adviser: Driving the commercialisation strategy as the company evolves from an R&D to a product-based business
23 January 2024 – TechBio company, Cytomos (www.cytomos.com) is pleased to announce the appointment of Dr Fernanda Masri as chief commercial and innovation officer and Dr Christel Fenge as techno-commercial adviser....
Category: BioManufacturing, Biotechnology
Posted: January 23, 2024
Middle Wing Building University of Edinburgh Easter Bush Campus Roslin EH25 9RG Scotland
Leading biometrics CRO Phastar to share vast statistical expertise with biotechs working to build the drugs of the future
23 January 2024 -- London, UK and North Carolina, US -- Phastar, a global specialist biometrics contract research organisation (CRO), has announced the launch of Stats Helpdesk, a new initiative...
Category: Biotechnology
Posted: January 23, 2024
Recipharm, Medspray and Resyca enter into exclusive license agreement to develop nasally-delivered drug products using proprietary soft mist technology
Partnership will help bring breakthroughs in the nasal delivery of fragile biologics and small molecules to market 23 January 2023 -- Stockholm, Sweden -- Recipharm, a leading contract development and...
Category: Drug Delivery
Posted: January 23, 2024
New £30m initiative to address global threat by accelerating the pace of antimicrobial innovation
Pioneering partnership to drive development of new tests and treatments to tackle deadly antimicrobial resistance, which could otherwise kill 10 million a year by 2050 19 October 2023 – Innovate...
Category: BioManufacturing, Drug Discovery
Posted: January 23, 2024
Shionogi announces agreement with SOBI on Fetcroja (cefiderocol) to expand access for patients with infections due to aerobic Gram-negative organisms in adults with limited treatment options.
Shionogi and Sobi have signed a distribution agreement for cefiderocol covering 13 countries in Central & Eastern Europe (CEE) Cefiderocol provides coverage against all Gram-negative pathogens considered of critical priority...
Category: BioManufacturing, Pharmaceutical
Posted: January 23, 2024
CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies
Strategic partnership harnesses respective organ-specific expertise to provide complete human-derived Organ-on-a-Chip solution for more accurate in vitro ADME predictions Early access to dual-organ model available through CN Bio’s Contract Research...
Category: Biotechnology
Posted: January 23, 2024
PlaqueTec and the Babraham Institute collaborate on phenotypic screen of coronary artery blood
Collaboration to develop a bespoke cell phenotyping assay for human blood Project aims to investigate cell types present in coronary artery samples from patients with CAD participating in PlaqueTec’s BIOPATTERN...
Category: Biotechnology
Posted: January 23, 2024
BIA unveils new data: UK leads Europe in cell and gene therapy as sector makes significant strides
18 January 2024 – London, UK – The UK is cementing its position as a global leader in cell and gene therapy, according to a new report released today by...
Category: Clinical Trials, Drug Discovery
Posted: January 23, 2024
Upper Ground Floor, Victoria House, Bloomsbury Square, London WC1B 4DA
Calluna Pharma launches and announces €75m Series A financing to develop novel therapies for inflammatory and fibrotic diseases
Clinical stage company formed from the merger of Oxitope Pharma and Arxx Therapeutics Calluna Pharma has a pipeline of selective antibodies targeting immunological diseases New company to complete multiple clinical...
Category: Drug Discovery, Pharmaceutical
Posted: January 23, 2024
SGD Pharma expands capacity of siliconised glass vials with the announcement of a new siliconisation line at its Center of Excellence for Type I glass in France
22 January 2023 -- Paris La Défense, France -- SGD Pharma, global market leader in moulded glass primary packaging solutions for the pharmaceutical industry, announces the opening of a new...
Category: Manufacturing and Packing
Posted: January 22, 2024
CellVoyant secures £7.6m seed funding to accelerate the development of stem cell therapies with AI
Investment will make stem cell-based therapies more efficient, scalable, and cost-effective 16 January 2024 - Bristol, UK – CellVoyant, an AI-first biotechnology spin-out from the University of Bristol, UK, accelerating...
Category: Biotechnology, Drug Discovery
Posted: January 19, 2024
Modular automation solution adds PACE to just-in-time clinical trials packing
16 January 2023 -- Somerset, UK -- A new modular automation system for clinical trials drug delivery – now in operation at the Medical Manufacturing Innovation Centre (MMIC) in Strathclyde...
Category: BioManufacturing
Posted: January 18, 2024
Kizoo leads financing round in Reservoir Neuroscience to restorehealth to the aging brain
18 January 2024 – San Francisco, CA, US / Berlin, Germany – Reservoir Neuroscience announced today the completion of a $4m financing round to support the development of new therapies...
Category:
Posted: January 18, 2024
AES Clean Technology expands senior leadership team with key appointment
18 January 2024 -- Pennsylvania, US -- A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as chief revenue officer (CRO). With 18 years of...
Category: Manufacturing and Packing
Posted: January 18, 2024
Vivtex and AI Proteins enter strategic R&D collaboration to develop novel, oral biologic therapies for inflammatory diseases
18 January 2024 – Cambridge/Boston, MA, USA – Vivtex Corporation (“Vivtex”), a biotech company aiming to transform the development of oral biologic therapies for major diseases, and AI Proteins, Inc.,...
Category: BioManufacturing, Drug Discovery
Posted: January 18, 2024
